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TransplantatABSTRACT
Background. The rapid intraoperative parathormone (PTH) and at central laboratory
PTH dosage gives similar results. The central laboratory provides results in longer times
and higher costs. Intraoperative measurement can reduce time and costs during
parathyroidectomy.
Methods. Twelve patients undergoing parathyroidectomy for hyperparathyroidism renal
transplant candidates were included. Diagnosis was made by laboratory tests (serum cal-
cium, PTH) and imaging techniques (ultrasonography and scintigraphy). All patients
presented PTH levels of >400 pg/mL (the limit value to be maintained in list for kidney
transplantation) and resistant to medical therapy. For each patient, 2 blood samples were
collected before surgery at anesthesia induction for PTH testing intraoperative (rapid
assay) and central laboratory, and 10 minutes after the removal of each gland. The times
from collectioneprocessing to communication to the surgeon of the results were compared
for both the methods. It was considered successful the abatement of PTH of 70% at rapid
intraoperative testing and consequently surgical intervention stopped before communica-
tion of central laboratory PTH testing.
Results. The average time of reporting the test results of the central laboratory was 41.5
minutes (SD  9), whereas with the rapid intraoperative PTH (ioPTH) testing the average
time was 9.9 minutes (SD  2.02). An average of 33.6 minutes of the duration per inter-
vention (SD  10.27) were virtually saved with the use of ioPTH testing. The 2 values of
the Pearson correlation (r) of 0.99 obtained (for baseline) and 0.975 (for the 10-minute)
lead us to conclude that there is an excellent correlation between the series of data.
Conclusions. Rapid ioPTH testing, owing to its accuracy, permits a dramatic reduction of
operating time for patients with secondary hyperparathyroidism that need to be treated
before inclusion on the waiting list.*Address correspondence to Giuseppe Damiano, MD, PhD,
Department of Surgical, Oncological, and Stomatological Disci-
plines, 129 Via del Vespro, 90127 Palermo, Italy. E-mail: giuse.
damiano@gmail.comTHE ACCURACY of commercial rapid intraoperativeparathormone (PTH) testing kits is well-validated
and the results are comparable with those obtained from
central laboratory methods [1]. The diffusion of intra-
operative PTH (ioPTH) devices revolutionized the surgical
approach to hyperparathyroidism. Complete surgical neck
exploration and the gross anatomy evaluation of para-
thyroid glands demanded of the surgeon nowadays is
enhanced by this powerful and rapid conﬁrmation of an
efﬁcient surgery, and helps to avoid prolongation andlsevier Inc. All rights reserved.
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ion Proceedings, 48, 311e314 (2016)unnecessary manipulation of patients. Patients on dialysis
experience more complications when surgery is prolonged.
Central laboratory testing is valid as a tardive guarantee of a
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Table 1. Laboratory Data
Patient Time of Blood Collection PTH Central Laboratory (pg/mL)
Central Laboratory
Time (min) ioPTH Values (pg/mL) ioPTH Testing Time (min) Operating Time (min)
1 Baseline 780 42 731 8 110
10 min 28 38 33 9
2 Baseline 1340 49 1289 10 85
10 min 83 39 76 11
3 Baseline 3201 51 3189 7 210
10 min 96 39 87 10
4 Baseline 1940 39 1870 9 66
10 min 159 41 139 11
5 Baseline 690 42 620 8 79
10 min 27 39 35 10
6 Baseline 2020 38 2034 12 96
10 min 36 40 29 9
7 Baseline 1125 38 1100 9 110
10 min 95 41 104 11
8 Baseline 3134 40 3031 13 77
10 min 40 42 25 7
9 Baseline 1340 39 1386 10 101
10 min 32 39 39 9
10 Baseline 689 43 598 8 68
10 min 41 45 34 7
11 Baseline 530 48 499 14 79
10 min 21 39 18 11
12 Baseline 458 43 515 14 115
10 min 52 42 43 11
Abbreviation: ioPTH, intraoperative parathormone.
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peptide has a half-life of 3e5 minutes in patients with
normal renal function. After parathyroidectomy, PTH pre-
sents a biphasic pattern of decrement with a very rapid
initial phase (2e4 minutes) and a subsequent smothering of
curve with a lower elimination speed (21e82 minutes) [2].
Nussbaum et al. [3] described the ﬁrst use of PTH
monitoring during parathyroidectomy. Other groups [4,5]
independently described the use of ioPTH monitoring to
guide the surgeon during parathyroidectomy.
The central laboratory of our Institution uses the PTH intact
STAT (short turnaround time) electrochemiluminescence
immunoassay of the Cobase 411 analyzer (Roche Diagnostics,
Basel, Switzerland). This third-generation assay uses a bio-
tinylated monoclonal antibody, which reacts with amino acids
26e32, and a capture ruthenium-complexed monoclonal anti-
body, which reacts with amino acids 55e64, and requires 9
minutes to provide results. The STAT-IO-I-PTH System
(Future Diagnostics, Nieuweweg, the Netherlands) is a third-
generation PTH assay (immunochemiluminometric) that re-
quires 7 minutes to perform the assay. Brieﬂy, it uses a 2
afﬁnity-puriﬁed goat polyclonal antibodies against PTH with a
sandwich technique for measuring (1e84) PTH (1 antibody
speciﬁc for the 1e34 amino acid segment and the other for the
35e84 or 39e84 carboxy segment). The kit consists of an in-
strument on a trolley in the actual or immediate proximity of
the operating room.
The criterion for evaluation of results in primary hyper-
parathyroidism is based on a cutoff of a 50% decrease inPTH in plasma levels; the evaluation of the results in sec-
ondary hyperparathyroidism is based on a cutoff of a 70%
decrease of PTH levels in plasma after 10 minutes from the
resection of the last gland or 85% after 15 minutes [6e8]. In
both cases, there is a sensitivity of 85% and a speciﬁcity of
100% when it is performed 10 minutes after surgical
resection; sensitivity increases to 97% when the sample is
taken 15 minutes after resection.
The rapid ioPTH assay represents a kind of “extempo-
raneous histological biochemical examination”: a signiﬁ-
cant reduction of PTH levels, in fact, is able to predict
healing in almost 100% of cases, demonstrating the
complete excision. On the contrary, a ﬁnding of increased
PTH values at the end of the intervention is a sign of
persistent disease and suggests continuing the surgical
exploration until the identiﬁcation and removal of all
pathologic tissue.
Therefore, this method of investigation not only “cer-
tiﬁes” the nature of the parathyroid tissue removed, but also
documents the absence of residual hyperfunctioning tissue,
thus making the exploration of not easily identiﬁed para-
thyroids not always necessary. The protocol adopted for the
ioPTH assay provides 2 measurements: one at baseline
(induction of anesthesia) the second at 10 minutes after the
removal of suspected glands. A decreased value of PTH
postablation of >70% (the so-called cutoff) compared with
the value before ablation (baseline value) is able to predict
the surgical excision of a hyperfunctioning gland with a
sensitivity of 98% and a speciﬁcity of 94% [6e8]. Failure to
Fig 1. Correlation plot of central laboratory and intraoperative parathormone (ioPTH) assay at baseline and at 10 minutes after com-
plete hyperfunctioning gland excision.
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parathyroid tissue.
In this study, we analyzed the comparison of time needed
to perform intraoperative testing and central laboratory
testing and the value obtained from the test.
MATERIALS AND METHODS
This study included 12 patients with secondary hyperparathyroidism
owing to chronic renal insufﬁciency who were candidates for renal
transplantation, but required parathyroidectomy to staying on the
waiting list. The diagnosis was made by laboratory tests (serum
calcium, PTH) and localization testing (ultrasonography and scin-
tigraphy). All patients presented PTH levels of >400 pg/mL (the
limit for maintaining the list for kidney transplantation; Table 1)
and were resistant to medical therapy. For each patient, blood
samples (collected by a dedicated peripheral vein cannula on the
foot) were taken at baseline (before the surgery but after the in-
duction of anesthesia) and 10 minutes after the removal of sus-
pected gland. Blood samples were analyzed initially with ioPTH
assay and the sample sent to central laboratory only in presence of
PTH reduction of >70%. The results were compared.
The criterion for evaluation of results was based on a cutoff
of 70% from baseline of PTH plasma levels at 10 minutes as
successful removal of abnormal parathyroid glands.
RESULTS
The average time for central laboratory testing (time from
blood collection-processing to reporting to the surgeon) was
41.5 minutes (SD  9); the rapid ioPTH testing the average
time was 9.9 minutes (SD  2.02). For each patient, the
reduction in operating time was calculated (the intervention
was considered successful in presence of a PTH of >70%
from baseline and consequently terminated). An average of
33.6 minutes (SD  10.27) were saved when the ioPTH
value was sufﬁcient to terminate the intervention before
central laboratory results were returned (Table 1).
The correlation between the 2 respective series of data
(baseline PTH central laboratory vs baseline ioPTH and
10-minute PTH central laboratory vs 10-minute ioPTH)veriﬁed the presence of a similar behavior (at high values of
a variable correspond with high values of the other and vice
versa). The 2 values of the Pearson Correlation (r) of 0.99
obtained (for baseline) and 0.975 (for the 10-minute) lead
use to conclude that there is an excellent correlation
between the series of same data; therefore, we do ﬁnd a
difference in measurement between the 2 instruments at
baseline and 10 minutes after complete excision of the hy-
perfunctioning parathyroid gland. The analysis of scatter
plots supports the thesis (Fig 1).DISCUSSION
According to our experience and a validated protocol,
we consider a decrease of 70% from baseline PTH
levels at 10 minutes and/or a decrease of 85% at 15
minutes as successful removal of abnormal parathyroid
glands [6e8].
The use of ioPTH testing has increased dramatically the
success of this kind of surgery. Imaging techniques are un-
able to detect abnormal glands, requiring complete surgical
exploration (basing on the gross anatomy morphology). The
reduced time required for considering successfully para-
thyroidectomy permits a reduction of anesthesia time,
global operative time up to a decrease of 30 minutes, and
costs for treatment.
Candidates for kidney transplantation may have spent years
on dialysis, have effects of uremia, and be taking drugs to
reduce the value of PTH [9]. In these patients, ioPTH testing
has been validated and problems related to a reduced PTH
clearance overcome [10]. These fragile patients may take
advantage of such a tailored surgery that avoid the complete
surgical exploration required in the past and make less difﬁcult
the stairway to transplant.REFERENCES
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